Advertisement
The median time from COVID-19 symptom onset to viral clearance is 36 days

Median of 36 Days Found From COVID-19 Symptom Onset to Viral Clearance

0
Slight increase in time from symptom onset to viral clearance seen with increasing age, disease severity
Among children with COVID-19 or seasonal influenza

Child Hospital, ICU Admission Rates Similar for COVID-19, Flu

0
But more clinical symptoms reported at the time of diagnosis for children with COVID-19 versus flu
In March 2020

Increase Seen in Hydroxychloroquine Rx by Nonroutine Specialists

0
New Rx increased 80-fold among specialists who do not typically prescribe these medications
From 2014 to 2018

Insurer, Insured Costs for HIV PrEP Rising in the United States

0
2014 to 2018 saw increase in estimated third-party, out-of-pocket payments per 30 TDF-FTC tablets
The U.S. Preventive Services Task Force (USPSTF) concludes that current evidence is inadequate for assessing the balance of benefits and harms of hearing loss screening for older adults. This finding forms the basis of a draft recommendation statement published online Sept. 8 by the USPSTF.

USPSTF: Evidence Lacking for Screening Elders for Hearing Loss

0
Evidence insufficient for assessing benefits and harms of screening in older adults without symptoms
Financial strain is associated with an increased risk for suicide attempts and should be considered when assessing mental health

Financial Strain Tied to Higher Risk for Suicide Attempts

0
Variables of debt, housing instability, unemployment, low income together increase risk 20-fold
Disease-modifying antirheumatic drug therapy for rheumatoid arthritis treatment also cuts cardiovascular disease risk

Early Therapy for Rheumatoid Arthritis May Slow Heart Disease

0
RA treatment response does not appear to impact improvement in vascular stiffness
A new portable COVID-19 test that can provide results within 15 minutes and process up to 30 samples an hour could be available by the end of the year

New COVID-19 Test Provides Results in 15 Minutes

0
Test correctly diagnoses infection 90 percent of the time and a negative result 100 percent of the time
A "potentially unexplained" illness in a participant has led AstraZeneca to halt a late-stage clinical trial of its COVID-19 vaccine.

Clinical Trial of AstraZeneca COVID-19 Vaccine Paused After Illness

0
Company investigating whether the illness may be a side effect of the vaccine
Current low-intensity smokers have an increased risk for respiratory and lung cancer mortality

Respiratory, Lung Cancer Death Up Even With Low-Intensity Smoking

0
Risks for respiratory and lung cancer mortality increased for those smoking <10 cigarettes per day